CEO Frazier Says He Understands Free Enterprise Project Warnings About ICER’s Support of Care Rationing and Questionable Drug Pricing Bridgewater, NJ/Washington, D.C. – The CEO of Merck and Co. dismissed a request from a shareholder activist today to end its relationship with the controversial Institute … Continue reading Merck Continues Support for Controversial Special Interest Group